Cannabinoid Research Program

About Cronos Group

Cronos Group's mission is to build a leading, science-driven cannabinoid platform that delivers high-quality products to global consumer and medical markets. A key achievement was securing a C$2.4 billion strategic investment from Altria Group in 2019, providing a robust balance sheet to fund R&D and international expansion. The company's strategy is anchored in differentiating through its fermentation-based cannabinoid production technology, brand portfolio management, and navigating complex international regulatory pathways. Its operational focus spans cultivation, product development, and distribution in key legal markets.

Therapeutic Areas